Differentiation and adaptation epigenetic networks: Translational research in gastric carcinogenesis

There are several kinds of epigenetic networks in the human body including the cell differentiation epigenetic network (DiEN) and the host adaptation epigenetic network (AdEN). DiEN networks are static and cell/tissue-specific. AdEN networks are variable and dependent upon environmental factors. DiEN and AdEN alterations can respectively serve as biomarkers for different kinds of diseases. Cancer is a consequence of accumulated pathophysiological adaptations of tissue stem cells to exposure of environmental carcinogens. Cancer cells are de-differentiated cells that obtain the capacity of unrestricted proliferation, local invasion, and distant migration/metastasis. Both DiEN and AdEN changes can be observed in cancer tissues. Alterations of DNA methylation are the most stable epigenetic modifications and can be sensitively detected in a small cell population. These advantages make DNA methylation the optimal biomarkers for detection of initiated cells in precancerous lesions and metastasis stem cells in cancer tissues. It has been proven that p16 methylation can be used as a diagnostic biomarker to determine malignant potential of epithelium dysplasia in many organs including the stomach. In a large-scale validation study on the DNA methylome of gastric carcinomas (GC), the methylation status of more than 90 CpG islands has been analyzed by DHPLC. Furthermore, GFRA1 demethylation and methylation of SRF and ZNF382 are frequent events during gastric carcinogenesis and consistently correlate to GC metastasis and overall survival of GC patients from China, Japan, and Korea, respectively. In a population study, it has been demonstrated that gradual increasing of plasma miR-211 and other miRNA levels may be an early risk predictor for GC development.

[1]  Tim Hui-Ming Huang,et al.  Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. , 2003, Cancer research.

[2]  J. Herman,et al.  Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. , 2006, Cancer research.

[3]  M. Robinson,et al.  Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA , 2012, Genome research.

[4]  D. Dolinoy,et al.  Timing is everything , 2011, Epigenetics.

[5]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[6]  Peter A. Jones,et al.  Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment. , 2007, Cancer research.

[7]  Ping Yang,et al.  CpG Site–Specific Hypermethylation of p16INK4α in Peripheral Blood Lymphocytes of PAH-Exposed Workers , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[8]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[9]  A. Bhattacharyya,et al.  A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.

[10]  Gangning Liang,et al.  DNA methylation screening identifies driver epigenetic events of cancer cell survival. , 2012, Cancer cell.

[11]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[12]  D. Kang,et al.  Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.

[13]  D. Deng,et al.  Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. , 2010, Advances in genetics.

[14]  Li Zhang,et al.  Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.

[15]  S. Rogers,et al.  p16 Promoter Methylation Is a Potential Predictor of Malignant Transformation in Oral Epithelial Dysplasia , 2008, Cancer Epidemiology Biomarkers & Prevention.

[16]  W. Reik,et al.  Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal , 2009, Nature Reviews Molecular Cell Biology.

[17]  D. Deng,et al.  A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues , 2011, BMC Medical Genetics.

[18]  Christoph Bock,et al.  Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk , 2012, Genome research.

[19]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[20]  Wei Ding,et al.  Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia , 2005, Nature Genetics.

[21]  J. Min,et al.  Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. , 2011, Molecular cell.

[22]  J. Ji,et al.  Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo , 2012, BMC Cancer.

[23]  Huidong Shi,et al.  Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. , 2002, Genome research.

[24]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[25]  D. Deng,et al.  Methylation of p 16 CpG Islands Associated with Malignant Transformation of Gastric Dysplasia in a Population-Based Study , 2004 .

[26]  D. Deng,et al.  Methylation of p16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia: A Prospective Cohort Study , 2009, Clinical Cancer Research.

[27]  Yang Zhang,et al.  Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: A population‐based study , 2009, International journal of cancer.

[28]  J. Ji,et al.  Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas , 2006, Laboratory Investigation.

[29]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[30]  Takeshi Toyoda,et al.  Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. , 2010, Cancer research.

[31]  D. Deng,et al.  Methylation of p16 CpG Islands Associated with Malignant Transformation of Gastric Dysplasia in a Population-Based Study , 2004, Clinical Cancer Research.

[32]  M. Pellegrini,et al.  Relationship between nucleosome positioning and DNA methylation , 2010, Nature.

[33]  Martin J Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[34]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[35]  J. Ji,et al.  Nucleosomes Correlate with In Vivo Progression Pattern of De Novo Methylation of p16 CpG Islands in Human Gastric Carcinogenesis , 2012, PloS one.

[36]  S. Powell,et al.  Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography. , 2002, Nucleic acids research.

[37]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[38]  K. Zhang,et al.  DNA Demethylation Dynamics in the Human Prenatal Germline , 2015, Cell.